戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tentially overcoming differences in PSC line differentiation potential.
2 ing progenitors with a predominant monocytic differentiation potential.
3 blasts had approximately 50% lower adipocyte differentiation potential.
4 bryonic tissue while maintaining a versatile differentiation potential.
5 aneous loss of pluripotency, and compromised differentiation potential.
6  engineer progenitor cells with multilineage differentiation potential.
7 r cell duplication in populations with equal differentiation potential.
8 oth phenotypes and restored normal stem cell differentiation potential.
9 opoietic progenitors to establish their full differentiation potential.
10 th preserved long-term in vivo lymphomyeloid differentiation potential.
11 ntify the lines exhibiting strong osteogenic differentiation potential.
12 population studied as HSPCs with multlineage differentiation potential.
13 fered in their metabolic characteristics and differentiation potential.
14 ssures favouring cell aneuploidy and loss of differentiation potential.
15 MSC marker profile and in vitro multilineage differentiation potential.
16 the presence of close analogues with varying differentiation potential.
17 itor cells with self-renewal and multipotent differentiation potential.
18 eptor antagonist resulted in altered myeloid differentiation potential.
19  stem cells are considered to have a limited differentiation potential.
20 ither DPSC proliferation rate or multipotent differentiation potential.
21  hematopoietic progenitors and had bilineage differentiation potential.
22 on, exhibit differences in proliferation and differentiation potential.
23 mbryonic stem cell phenotype and pluripotent differentiation potential.
24 e proliferation ability, thus changing their differentiation potential.
25 hondria and require UCP2 repression for full differentiation potential.
26  in genome-wide DNA methylation profiles and differentiation potential.
27 ting a progressive decrease in hematopoietic differentiation potential.
28 ant proliferative, chemotaxis, adhesion, and differentiation potential.
29 e capacity for self-renewal and multilineage differentiation potential.
30  cells yet differ in molecular phenotype and differentiation potential.
31 yeloid progenitors (EMPs) that lack lymphoid differentiation potential.
32 sider implications for hESC pluripotency and differentiation potential.
33  but not their maintenance, proliferation or differentiation potential.
34 ike cells have self-renewal and multilineage differentiation potential.
35  prethymic, age-related defects in T-lineage differentiation potential.
36 vels of endoglin (NCSC(CD105+)) had myogenic differentiation potential.
37 accelerates maturation and polarizes hES-NSC differentiation potential.
38 in Lmna(-/-) myoblasts resulted in increased differentiation potential.
39 er the JAK2 V617F-positive cells had altered differentiation potential.
40 derived stem cells (ADSCs) have multilineage differentiation potential.
41 -derived pluripotent stem cells with a broad differentiation potential.
42 mpaired differentiation kinetics and reduced differentiation potential.
43 enerated uncommitted cells with multilineage differentiation potential.
44 ed this compartment, but retain multilineage differentiation potential.
45 a transformed phenotype and disrupting their differentiation potential.
46 o establish new stage- or cell-type-specific differentiation potential.
47 developmental stage thymocytes lose this G/M differentiation potential.
48 planted into syngeneic rats to examine their differentiation potential.
49 played less CD45RA, and had little B-lineage differentiation potential.
50 an ongoing immune response, regardless of Th differentiation potential.
51  pRB(-/-) 3T3 cells exhibit defects in their differentiation potential.
52 cytic progenitor with intrinsic biphenotypic differentiation potential.
53 iciency does not abrogate myeloid progenitor differentiation potential.
54 C) are cells with self-renewing multilineage differentiation potential.
55 clonogenic potential and increased B-lineage differentiation potential.
56 HSPCs), without impairing cell viability and differentiation potential.
57 d allows the ranking of cells based on their differentiation potential.
58 n (STAT) 3 signaling pathway, and osteogenic differentiation potential.
59 ) cell derived SG-MSCs revealed multilineage differentiation potential.
60 l, serial clonogenicity, and multigerm layer differentiation potential.
61  LMPP/MPP4 with loss of lymphoid priming and differentiation potential.
62  progenitor cell populations with restricted differentiation potential.
63 markers and demonstrated robust mineralizing differentiation potential.
64 ed MSCs for self-renewal, proliferation, and differentiation potential.
65  is regulated by progenitor availability and differentiation potential.
66 eased cell death or altered neural precursor differentiation potential.
67 teoblastogenic, chondrogenic, and adipogenic differentiation potentials.
68 ughter cells with differing self-renewal and differentiation potentials.
69  cells that may reflect molecular priming of differentiation potentials.
70 either A-type lamins or emerin have impaired differentiation potentials.
71 fibroblasts possessed trilineage mesenchymal differentiation potentials.
72 ogenic assays were used to investigate their differentiation potentials.
73 are defined by self-renewal and multilineage differentiation potentials.
74 ctive of tissue of isolation, equal in their differentiation potential?
75 iple BM populations have intrinsic T lineage differentiation potential, a small subset of multipotent
76 mice, displaying increased proliferation and differentiation potentials (adipogenesis, osteogenesis a
77  marrow cells containing lymphoid-restricted differentiation potential after i.v. transplantation.
78 ulated young mice, and retained multilineage differentiation potential after multiple rounds of seria
79 aracteristics in vitro and proliferative and differentiation potential after transplantation into adu
80                                         Full differentiation potential along with self-renewal capaci
81 gramming event to acquire a remarkably broad differentiation potential and ability to migrate through
82  parthenogenesis and demonstrated their wide differentiation potential and applicability for genetic
83 om hESCs (hESCd-MSCs) that have multilineage differentiation potential and are capable of producing f
84 teoclasts from BgnFmod KO mice having higher differentiation potential and being more active compared
85 oid progenitors exhibiting CD14-dependent DC differentiation potential and CD14(+)CD1a+ DC precursors
86 om both sources exhibited similar trilineage differentiation potential and cell surface marker expres
87 ryonic progenitor cells with hemangioblastic differentiation potential and conclude that embryonic pr
88 These progenitor cells demonstrated bipotent differentiation potential and could generate endothelial
89 cells differ from each other with respect to differentiation potential and fates.
90 prisingly, GPx2-suppressed cells also lacked differentiation potential and formed slow-growing undiff
91           While both cell types show similar differentiation potential and forward scatter values, th
92                            Understanding the differentiation potential and function of these cells ma
93 monocyte subpopulations, understanding their differentiation potential and function.
94 on therapies by virtue of their multilineage differentiation potential and immunogenicity; however, r
95 ntense investigation in HCT because of their differentiation potential and immunomodulatory propertie
96 multipotent cells with in vitro multilineage differentiation potential and in vivo engraftment potent
97 al, and had normal transcriptional profiles, differentiation potential and karyotypes.
98 ells, with which they share gene expression, differentiation potential and lineage restriction.
99 engthy protocols or a progressive decline in differentiation potential and physiological function wit
100 n knockout cells decreased proliferation and differentiation potential and recapitulated the WT pheno
101 tant in defining cellular properties such as differentiation potential and responsiveness to developm
102 on of lung progenitor markers, multi-lineage differentiation potential and self-renewal activity.
103 iding with a reduction in both smooth muscle differentiation potential and TGFbeta1 responsiveness.
104 cific stem/precursor cells that retain broad differentiation potential and, more importantly, develop
105 ain long-term repopulation and multi-lineage differentiation potential, and can improve biochemical a
106 gle-cell assays of HSC quiescence, stemness, differentiation potential, and epigenetic state to probe
107  in an intermediate state with bidirectional differentiation potential, and found the balance between
108 rbor an appropriate gene edit, pluripotency, differentiation potential, and genomic stability are typ
109 re the most proliferative, hold the greatest differentiation potential, and have the lowest rate of c
110 ity of the hemangioma stem cells, diminishes differentiation potential, and inhibits the vasculogenic
111 h passage 11 for phenotype, gene expression, differentiation potential, and karyotype.
112  at histone H3 serine 10 (H3S10P), decreased differentiation potential, and premature cellular senesc
113 e have distinct patterns of gene expression, differentiation potential, and response to environmental
114 itors are hyperproliferative, show decreased differentiation potential, and show increased self-renew
115 + CD38- progenitor cells have a multilineage differentiation potential, and that Tpo promotes prolong
116 itor populations with granulocyte/macrophage differentiation potential are efficiently immortalized i
117 rs that regulate cancer stem-like cell (CSC) differentiation potential are largely unknown.
118 rs did not restrict, but rather switch their differentiation potential as they developed.
119  scaffolds exhibit an increase in osteogenic differentiation potential, as evidenced by increased alk
120 progenitor populations for T cell growth and differentiation potential, as well as for clonogenic T o
121 riability of their osteogenic and adipogenic differentiation potential, as well as their ability to m
122 rimitive human progenitors with multilineage differentiation potential, as well as to evaluate future
123  the dissociated cells retained their normal differentiation potentials, as shown by their capabiliti
124 hagocytic activity, and a greater osteoclast differentiation potential at suboptimal RANK-L concentra
125 ested that bone marrow cells possess a broad differentiation potential, being able to form new liver
126 ndrogenic potential assays revealed retained differentiation potentials between transduced and wild-t
127 ariability in frequency, immunophenotype and differentiation potential, both between and even within
128 ers of haematopoietic stem cells with normal differentiation potential, but loss of cell-autonomous s
129 Ps, with very limited granulocyte/macrophage differentiation potential, but they can differentiate in
130 ssemble HC variable region genes and assayed differentiation potential by recombination activating ge
131 development cells become restricted in their differentiation potential by repressing alternative cell
132 n impaired, however, in determining cellular differentiation potentials by a lack of short-term funct
133 7, and CD94 cell surface expression, lineage differentiation potentials, capacity for cytokine produc
134 ogeneous, and displays distinct multilineage differentiation potential, cell cycle profile, prolifera
135 ibited increased TRPV4 activity and enhanced differentiation potential compared with normal human lun
136 d from TRPV4-knockout mice showed diminished differentiation potential compared with wild-type mice.
137 e less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC.
138 ple distinct subsets that display growth and differentiation potential consistent with being canonica
139 ervoir of CD45-CD34(+) EPCs with endothelial differentiation potential, containing a mean of 263 time
140 yed differences in fate-regulating genes and differentiation potential depending on their rostrocauda
141 lls affected by BRAF mutation had a range of differentiation potentials depending on exogenous signal
142                           In PSCs with lower differentiation potential, DNA replication was incomplet
143  subunit Dpf2 maintains pluripotency and ESC differentiation potential. Dpf2 co-occupies enhancers wi
144 the sequential loss of erythroid and then GM differentiation potential during early hematopoiesis.
145 genitors are protean and able to alter their differentiation potential during embryogenesis and after
146 oietic cells are tightly restricted in their differentiation potential during mouse embryo developmen
147 rm self-renewing capacities and multilineage differentiation potential during physiological and regen
148 pression for protecting stem cells and their differentiation potential during viral infection.
149 ation capacity and restricted cardiovascular differentiation potentials during cardiac transdifferent
150 pacity in vivo but completely lacked myeloid differentiation potential either in vivo or in vitro.
151 n upon which TSCs are cultured changes their differentiation potential from TGCs to multinucleated sy
152 g progenitor cells, and possess multilineage differentiation potential generating functional prostati
153                     To this end, we examined differentiation potential, global gene expression patter
154 culture and transplantation assays to assess differentiation potential have led to extraordinary prog
155 id cell lines with neutrophil and macrophage differentiation potential in about 50% of the infected c
156                  Thus, B2 cells have B1 cell differentiation potential in addition to their classical
157 isoform preferentially blocks rhabdomyoblast differentiation potential in cell culture and in vivo.
158 potent stem cells (hiPSCs) with wide lineage differentiation potential in culture.
159 cells retain age-related stem- and endocrine-differentiation potential in culture.
160 anscription factors and surface markers, and differentiation potential in embryoid body formation and
161 ts expression levels correlate with fat cell differentiation potential in humans.
162    Single BASCs had bronchiolar and alveolar differentiation potential in lung endothelial cell cocul
163 s the balance of myeloid versus T lymphocyte differentiation potential in lymphomyeloid-primed progen
164 amycin targets the self-renewal and vascular differentiation potential in patient-derived hemangioma
165  CD29(low) luminal progenitors with enhanced differentiation potential in vitro and in vivo.
166 r to bone marrow HSPCs and have multilineage differentiation potential in vitro and in vivo.
167 FP mice and evaluate their proliferative and differentiation potential in vitro.
168 ted long-term proliferation and multilineage differentiation potential in vitro.
169 perties in vitro and their proliferative and differentiation potential in vivo after transplantation
170 rogenitor cells; however, their identity and differentiation potential in vivo remain poorly characte
171     Lymphoid-specified MPPs have low myeloid differentiation potential in vivo, but potently differen
172 inocyte subpopulations with increased growth/differentiation potential, including clonal growth capab
173 ely impact either clonogenic or multilineage differentiation potential, indicating a selective depend
174 pe and possessing unlimited self-renewal and differentiation potential, induced pluripotent stem cell
175 bility with respect to CHCHD2 expression and differentiation potential is caused by clonal variation
176                  Their migration pattern and differentiation potential is distinct from anterior fore
177                       At each stage, lineage differentiation potential is restricted, coupled with th
178  impact of genetic modifications on relative differentiation potential, it is now evident that a bias
179     Cell clones were evaluated for their O/C differentiation potential, metabolic activity, and expre
180                            To evaluate their differentiation potential, NEPECs were heritably marked
181 tential in myoblasts, the augmented myogenic differentiation potential observed is likely the result
182                                          The differentiation potential of 17 human embryonic stem (hE
183 r, the EVE had no effect on proliferation or differentiation potential of adipose stem cells.
184 se model can be a valuable tool to study the differentiation potential of adult human stem cells.
185 o the mammary epithelial hierarchy, the true differentiation potential of adult MaSCs remains unclear
186                       Here, we show that the differentiation potential of adult rodent OPCs decreases
187                             The multilineage differentiation potential of adult tissue-derived mesenc
188                            Impaired lymphoid differentiation potential of aged LMPP/MPP4 is not rescu
189                              We examined the differentiation potential of an adult liver stem cell li
190 f B-ALL and suggest that engaging the latent differentiation potential of B-ALL cells may provide new
191  reduction in the frequency and self-renewal/differentiation potential of basal MaSCs.
192                                          The differentiation potential of BECs and LECs in vivo and i
193 itutive Notch activity suppresses the acinar differentiation potential of CACs.
194 rs influence the epigenetic conformation and differentiation potential of cells during reprogramming
195                        Here, we examined the differentiation potential of cells expressing such linea
196 ells; however, CTGF is down-regulated as the differentiation potential of committed pre-osteoblasts i
197 3 is required for both the proliferative and differentiation potential of developmentally mature kera
198 ted gene expression to the proliferation and differentiation potential of early human bone marrow lym
199 egies should concentrate on manipulating the differentiation potential of endogenous or exogenous pre
200            The phenotype characteristics and differentiation potential of enriched cells were analyze
201      Acute deletion of BAF250a disrupted the differentiation potential of ES cells by altering the ex
202 C self-renewal, but significantly alters the differentiation potential of ESCs, particularly along th
203                                          The differentiation potential of GRP cells is retained throu
204 of the human hair follicle that preserve the differentiation potential of HAP stem cells.
205                                   The B cell differentiation potential of HNF1A(-/-) common lymphoid
206  the retinoblastoma protein and enhances the differentiation potential of hPSCs across all germ layer
207 ythroid, accompanied by a parallel change in differentiation potential of HSC/MPPs, which we function
208                         The self-renewal and differentiation potential of human embryonic stem cells
209 nted here offer new tools for harnessing the differentiation potential of human ESCs.
210 f this study was to characterize the cardiac differentiation potential of human iPS cells generated u
211 mmunophenotype, transcriptional profile, and differentiation potential of individual MEP cells.
212 or formation and a determinant of the growth/differentiation potential of keratinocyte subpopulations
213 layed differentiation kinetics and decreased differentiation potential of lamin A/C-deficient and eme
214 e expression of premarked genes and enhanced differentiation potential of Lsh(-/-) iPS cells toward t
215                                          The differentiation potential of mouse embryonic stem cells
216 beta-catenin in mouse osteoblasts alters the differentiation potential of myeloid and lymphoid progen
217 r observe enhanced unbiased lineage-specific differentiation potential of naive hESCs converted in NC
218                                          The differentiation potential of NCC varies according to the
219                     We tested the growth and differentiation potential of NCSCs at approximately 5% O
220 ng the TBI-responsive migratory behavior and differentiation potential of neural progenitor cells (NP
221  challenged by reports that showed a broader differentiation potential of neural stem cells, in vitro
222                                     When the differentiation potential of NG2+ cells in vitro was exa
223 iological changes in OPCs correlate with the differentiation potential of OPCs; thus, they may underl
224 ciated previously with the proliferation and differentiation potential of OPs.
225 sion seems to correlate with neuroectodermal differentiation potential of pluripotent stem cells.
226 ce and differentiation, we have analyzed the differentiation potential of progenitors derived from em
227 l blood indices, and corrected the defective differentiation potential of progenitors in the erythroi
228 etic progenitor assays demonstrated that the differentiation potential of PV was already skewed towar
229              To examine the self-renewal and differentiation potential of Rad-NSCs in vivo, Rad-NSCs
230                      The ability to quantify differentiation potential of single cells is a task of c
231               In this study, we analyzed the differentiation potential of single thymocytes from wild
232 rm-free mice display reduced proportions and differentiation potential of specific myeloid cell proge
233 neity in G1 length underlies the pluripotent differentiation potential of stem cell populations.
234                                          The differentiation potential of stem cells is influenced by
235 ether an open chromatin is necessary for the differentiation potential of stem cells, and which molec
236 e demonstrate the in vitro proliferative and differentiation potential of stem/progenitor cells, adul
237                                          The differentiation potential of T lineage cells becomes res
238 MISTRG MDS-PDX demonstrate the cytotoxic and differentiation potential of targeted therapeutics provi
239  In short, slower proliferation and abnormal differentiation potential of tetraploid ESCs might be tw
240 g the dKO-nmMSCs with dKO-MPCs, the myogenic differentiation potential of the dKO-MPCs was reduced.
241 nce even low vector expression may alter the differentiation potential of the iPSCs or induce maligna
242       The viability, proliferation rate, and differentiation potential of the labelled cells were the
243       Zeb2 genetic inactivation impaired the differentiation potential of the V-SVZ niche in a cell-a
244                       The relatively uniform differentiation potential of the Wnt(high) and Wnt(low)
245                        The origin and growth/differentiation potential of these c-kit-positive cells
246 decreasing average mechanical compliance and differentiation potential of these cells, although expre
247 han nonpolar progenitors, leading to a lower differentiation potential of these cells.
248 f KLRG1(+) ILCs is consistent with the broad differentiation potential of these cells.
249                                          The differentiation potential of these MSCs combined with ex
250 that cellular origin influences the in vitro differentiation potentials of iPSCs into embryoid bodies
251 howed a direct correlation between DDIT4 and differentiation potentials of MSC.
252 ibute to genomic instability and the diverse differentiation potentials of reprogrammed PSCs.
253 lations often have reduced proliferation and differentiation potential, or have become immortalized c
254  expressed EphB4 in cell lines of restricted differentiation potential promoted megakaryocytic differ
255 g and comparing the hiPSC clonal and/or line differentiation potential provides a tool for large scal
256 ed-HSCs (iHSCs), possess clonal multilineage differentiation potential, reconstitute stem/progenitor
257 een claimed to possess an unexpectedly broad differentiation potential (referred to here as plasticit
258 progenitor pool of spermatogonia, markers of differentiation, potential regulators of meiosis, RNA tu
259     To test whether these changes in Th cell differentiation potential rendered Grb2(fl/fl) CD4cre(tg
260                      Finally, to confirm the differentiation potential, reporter human iPS clones wer
261 ic cells are expected to possess high growth/differentiation potential, required for organ morphogene
262            Furthermore, CCR9(+) MPPs possess differentiation potential similar to that of ETPs, with
263 en their unique function in self-renewal and differentiation potential, stem cells might be used to r
264 tion defect with minimal effect on erythroid differentiation potential, suggesting the mechanism of a
265 neurons, the two hESC lines exhibit distinct differentiation potentials, suggesting that they are pre
266 eir genomic instability and diminishes their differentiation potential, supporting the notion that ac
267 enewing progenitor with limited multilineage differentiation potential termed the erythromyeloid prog
268 intain a latent granulocyte/macrophage (G/M) differentiation potential that can be initiated by signa
269      However, they maintain a latent myeloid differentiation potential that can be initiated by stimu
270 ns house pools of SCs with proliferative and differentiation potentials that diverge from this templa
271 sively without obvious senescence or loss of differentiation potential, they may be an ideal cell sou
272 that become increasingly restricted in their differentiation potential through oligopotent and then u
273 t nuclear reprogramming can restore terminal differentiation potential to human-derived cancer cells,
274 elopmental plasticity, thereby expanding the differentiation potential to include the neuronal lineag
275 F4 or FGF2 together with heparin rescued the differentiation potential to neural progenitors and furt
276 l brain tumors are similar in appearance and differentiation potential to neural stem and progenitor
277 (termed R-NSCs), a novel NSC type with broad differentiation potential toward CNS and PNS fates and c
278                  In addition, these SCs show differentiation potential toward mesenchymal lineages, a
279 d both neuronal and glial progeny, but their differentiation potential toward multiple region-specifi
280 erative medicine has been to direct the wide differentiation potential toward the derivation of a spe
281 stem cells (hESCs) have different and biased differentiation potentials toward either neuroectoderm o
282 Although early pro-B cells have lost myeloid differentiation potential, transplantation experiments d
283  during hematopoiesis, with stepwise loss of differentiation potential ultimately resulting in lineag
284 helial SCs, their tissue location, and their differentiation potential under physiological conditions
285 scence and maintained their multipotency and differentiation potential until passage 11 and beyond.
286  Thus, IRF8 not only bestows monocyte and DC differentiation potential upon mononuclear phagocyte pro
287 ght, we assessed relative tumorigenicity and differentiation potential via xenotransplantation.
288                                              Differentiation potential was evaluated by injecting cel
289                                              Differentiation potential was examined for changes in ph
290                               Monocytic cell differentiation potential was retained in left-shifted b
291                                              Differentiation potential was tested in novel, single-ce
292   Six imidazole derivatives with high kinase differentiation potential were identified.
293 D repopulating cells (SRC) with multilineage differentiation potential were maintained in FL-SCF-IL-7
294 ing fibrocytes, with greater myofibroblastic differentiation potential, were observed in patients wit
295 thelial cells (hAECs), which possess hepatic differentiation potential, were transplanted into the mi
296  previously showed that they acquire broader differentiation potential when cultured under embryonic-
297 cdpk3- ookinetes maintain their full genetic differentiation potential when microinjected into the mo
298 rogenitors (CLPs), maintain a latent myeloid differentiation potential, which can be initiated by sti
299 oblasts fail to proliferate but retain their differentiation potential, while deletion of Mll2 had no
300 ain long-term repopulation and multi-lineage differentiation potential with serial transplantation.

 
Page Top